GLPwatch
Incretin-based therapy and the quest for sustained improvements in β-cell health.
Diabetes Care · 2011
Last updated 2026-05-28| Journal | Diabetes Care, 2011 |
|---|---|
| Citations | 18 |
| Relative citation ratio | 0.50 |
| NIH percentile | 29 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 21868783 ↗